跳转至内容
Merck
CN

L3170

脂肪酶 来源于念珠菌

greener alternative

recombinant, expressed in Aspergillus niger

别名:

脂肪酶CALB L

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
12352204
NACRES:
NA.54
MDL number:
Recombinant:
expressed in Aspergillus niger
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


recombinant

expressed in Aspergillus niger

Quality Level

form

aqueous solution

enzyme activity

≥5000 LU/g

greener alternative product characteristics

Waste Prevention
Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.

sustainability

Greener Alternative Product

greener alternative category

storage temp.

2-8°C

General description

假丝酵母脂肪酶南极假丝酵母脂肪酶B是一种丝氨酸水解酶,属于α/β水解酶折叠类。它由Ser、His和Asp/Glu催化三元组组成,并具有仲醇结合口袋。在结构上,CALB以开放和封装两种构象存在并且活性部位使用小盖覆盖。共有10种脂肪酶与白色念珠菌相关。
我们致力于为您提供更环保的替代产品,以符合“绿色化学的12项原则”的一项或多项原则要求。该产品针对生物柴油研究进行了优化,可提高能效并防止浪费。有关详细信息,请参阅《Biofiles》的文章

Application

使用假丝酵母脂肪酶
  • 制备金纳米颗粒(AuNPs)偶联物以用于生物物理研究
  • 用于脂肪酶活力测定
  • 固定化Immobead-350

Biochem/physiol Actions

假丝酵母脂肪酶南极假丝酵母脂肪酶B是是仲醇对映体特有的。它具有广泛的工业应用。一般来说,脂肪酶催化三酰基甘油的合成和分解。南极假丝酵母脂肪酶B (CALB)经过界面激活,是一种广受欢迎的脂肪酶。

Analysis Note

液体的最低含量为5,000 LU/G


存储类别

10 - Combustible liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

常规特殊物品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Maísa Pessoa Pinheiro et al.
Biotechnology progress, 34(4), 878-889 (2018-03-15)
Novozyme 435, which is a commercial immobilized lipase B from Candida antarctica (CALB), has been proven to be inadequate for the kinetic resolution of rac-indanyl acetate. As it has been previously described that different immobilization protocols may greatly alter lipase
Minshan Hu et al.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 21(6), 751-757 (2013-03-05)
Diet induces changes in plasma lipid profiles, and the plasma lipid profiles vary among different genetic backgrounds. The aim of this study was to investigate how a high-carbohydrate (high-CHO) diet interacts with hepatic lipase G-250A promoter polymorphism to affect the
Effects of bezafibrate treatment in a patient and a carrier with mutations in the PNPLA2 gene, causing neutral lipid storage disease with myopathy.
Tineke van de Weijer et al.
Circulation research, 112(5), e51-e54 (2013-03-02)



全球贸易项目编号

货号GTIN
L3170-50ML04061833950913